MX2015006970A - Composiciones del virus del sindrome reproductor y respiratorio de porcino y sus usos. - Google Patents

Composiciones del virus del sindrome reproductor y respiratorio de porcino y sus usos.

Info

Publication number
MX2015006970A
MX2015006970A MX2015006970A MX2015006970A MX2015006970A MX 2015006970 A MX2015006970 A MX 2015006970A MX 2015006970 A MX2015006970 A MX 2015006970A MX 2015006970 A MX2015006970 A MX 2015006970A MX 2015006970 A MX2015006970 A MX 2015006970A
Authority
MX
Mexico
Prior art keywords
virus
respiratory syndrome
porcine reproductive
syndrome virus
virus compositions
Prior art date
Application number
MX2015006970A
Other languages
English (en)
Other versions
MX366051B (es
Inventor
Federico Zuckermann
Gabriela Calzada-Nova
William Schnitzlein
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of MX2015006970A publication Critical patent/MX2015006970A/es
Publication of MX366051B publication Critical patent/MX366051B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporcionan en la presente modalidades relacionadas con el virus del síndrome reproductor y respiratorio de porcino (PRRS), composiciones que comprenden el virus, y métodos para utilizar el virus. El virus puede usarse para inmunizar un mamífero, incluyendo cerdos. Son provistos los métodos para generar una respuesta inmunitaria frente al virus PRRS en cerdos por la administración de una composición que comprende el virus.
MX2015006970A 2012-12-07 2013-12-03 Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos. MX366051B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261734919P 2012-12-07 2012-12-07
PCT/US2013/072922 WO2014089117A1 (en) 2012-12-07 2013-12-03 Porcine reproductive and respiratory syndrome virus compositions and uses thereof

Publications (2)

Publication Number Publication Date
MX2015006970A true MX2015006970A (es) 2015-12-16
MX366051B MX366051B (es) 2019-06-26

Family

ID=50881168

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006970A MX366051B (es) 2012-12-07 2013-12-03 Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos.

Country Status (6)

Country Link
US (2) US9149518B2 (es)
EP (1) EP2929018A4 (es)
CN (1) CN105308178B (es)
CA (1) CA2892948C (es)
MX (1) MX366051B (es)
WO (1) WO2014089117A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2929018A4 (en) * 2012-12-07 2016-07-13 Univ Illinois PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS COMPOSITION AND USES THEREOF
KR101624485B1 (ko) 2014-08-13 2016-05-26 전북대학교산학협력단 돼지생식기호흡기증후군 바이러스(prrsv) 변이주 및 이를 포함하는 돼지 생식기 호흡기 증후군 예방 또는 치료용 백신 조성물
KR101692480B1 (ko) 2015-07-01 2017-01-05 계명대학교 산학협력단 가축 바이러스 질환 예방 또는 치료용 조성물
CN107496914B (zh) * 2017-08-28 2021-01-01 洛阳赛威生物科技有限公司 一种佐剂组合物及其制备方法和应用
CN109666719A (zh) * 2018-12-09 2019-04-23 华中农业大学 一种提高细胞分辨率染色质可及性的方法
CN110283822B (zh) * 2019-06-25 2022-11-18 华中农业大学 一种猪PMAIP1基因siRNA干扰片段及其应用
WO2023128051A1 (ko) * 2021-12-30 2023-07-06 주식회사 바이오포아 돼지생식기호흡기증후군바이러스 유래 펩타이드를 발현하는 키메라 바이러스 및 이를 포함하는 백신 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103460C (en) 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
CA2076744C (en) 1991-08-26 2000-06-27 Danny W. Chladek Viral agent associated with mystery swine disease
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US6251397B1 (en) 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
ATE197314T1 (de) 1993-02-08 2000-11-15 Bayer Ag Verfahren zum vermehren des das reproduktions- und atemwegs-syndrom verursachenden schweinevirus und dessen verwendung als impfstoff.
US6221361B1 (en) * 1995-01-19 2001-04-24 Syntro Corporation Recombinant swinepox virus
US5690940A (en) 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
US5866401A (en) 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
DE69837992T2 (de) 1997-05-06 2008-03-20 Boehringer Ingelheim Vetmedica Gmbh Prrsv-antigene, die auf peptidsequenzen des prrs-virus basieren, für die verwendung als impfstoff und für diagnostische tests
CA2370372C (en) 1999-04-22 2009-02-24 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
WO2002060921A2 (en) 2000-11-09 2002-08-08 Board Of Trustees Of The University Of Illinois Enhancement of immune response to vaccine by interferon alpha
US20040073021A1 (en) 2001-10-11 2004-04-15 Zuckermann Federico A. Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains
CA2418780A1 (en) 2002-02-28 2003-08-28 Institut National De La Recherche Scientifique Synthetic genes encoding proteins of porcine reproductive and respiratory syndrome virus and use thereof
RU2007130801A (ru) 2005-01-13 2009-02-20 Берингер Ингельхайм Ветмедика Гмбх (De) Улучшенные вакцины против репродуктивно-респираторного синдрома свиней (prrs)
US20100227339A1 (en) 2005-12-02 2010-09-09 Iowa State University Research Foundation, Inc. Differential immunoassay for prrs vaccine antibody
AR064888A1 (es) 2007-01-12 2009-04-29 Univ Illinois Celulas no simias para el crecimiento del virus del sindrome reproductor y respiratorio porcino (prrs)
US9132185B2 (en) 2010-06-02 2015-09-15 Virginia Tech Intellectual Properties, Inc. Modified live-attenuated vaccines (MLV) created by DNA shuffling against porcine reproductive and respiratory syndrome virus (PRRSV)
ME02271B (me) 2011-02-17 2016-02-20 Boehringer Ingelheim Vetmedica Gmbh Novi evropski prrsv soj
EP2929018A4 (en) * 2012-12-07 2016-07-13 Univ Illinois PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS COMPOSITION AND USES THEREOF

Also Published As

Publication number Publication date
US20160074503A1 (en) 2016-03-17
CA2892948C (en) 2022-09-20
CN105308178B (zh) 2019-06-07
EP2929018A1 (en) 2015-10-14
US20140161768A1 (en) 2014-06-12
MX366051B (es) 2019-06-26
CA2892948A1 (en) 2014-06-12
US9149518B2 (en) 2015-10-06
CN105308178A (zh) 2016-02-03
WO2014089117A1 (en) 2014-06-12
US9687543B2 (en) 2017-06-27
EP2929018A4 (en) 2016-07-13

Similar Documents

Publication Publication Date Title
MX366051B (es) Composiciones del virus del síndrome reproductor y respiratorio de porcino y sus usos.
AU2018253544A1 (en) Methods for treating or preventing asthma by administering an IL-4R antagonist
MX2016003419A (es) Metodos y composiciones para sindrome respiratorio coronavirus de oriente medio (mers-cov) inmunogenico.
MX2016007063A (es) Peptidos terapeuticos.
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
MX2013013906A (es) Vacunas combinadas para prevencion de infecciones por virus porcino.
HK1227279A1 (zh) 在斷奶之前對抗豬繁殖與呼吸綜合徵(prrs)病毒的有效疫苗接種
PH12015500092A1 (en) Compositions for immunising against staphylococcus aureus
PH12015501354A1 (en) Antiviral compounds
MD20140035A2 (ro) Metodă de tratament al hepatitei virale C
IN2012DN01898A (es)
MX2015010305A (es) Vacuna de combinacion para virus sincitial respiratorio e influenza.
EA201391183A1 (ru) Способы усиления иммуногенспецифических иммунных ответов при помощи векторных вакцин
EA202090699A3 (ru) Композиции, содержащие буфер, вакцины, которые содержат композиции, содержащие буфер, и пути их применения
BR112015012841A2 (pt) composição imunogênica, vacina, e, uso de uma composição imunogênica
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
CL2012003458A1 (es) Vector que comprende un polipeptido antigénico de campylobacter; composicion farmacéutica que comprende dicho vector; uso del vector para mejorar respuesta inmune del sujeto al polipéptido antigénico.
NZ618158A (en) Compositions and methods for administration of vaccines against dengue virus
PH12015502082A1 (en) Improved stability and potency of hemagglutinin
CL2016000300A1 (es) Métodos terapéuticos
EP2977451A4 (en) NOVEL VIRUS OF KOREAN PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS)
MX347911B (es) Vacuna contra virus de diarrea viral de bovinos.
MX2019002024A (es) Antigenos de pertussis acelulares no entrelazados para uso en vacunas de combinacion.
EA033027B1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
MX369039B (es) Vacuna contra el circovirus porcino tipo 2.

Legal Events

Date Code Title Description
FG Grant or registration